{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:42:31Z","timestamp":1785404551264,"version":"3.56.0"},"reference-count":32,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babes University of Medicine and Pharmacy, Timisoara"},{"id":[{"id":"https:\/\/ror.org\/00afdp487","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background and Objectives: Laryngeal cancer imposes substantial inpatient costs in middle-income health systems. We described recent trends in laryngeal cancer hospitalizations in Romania, estimated hospital expenditure, and modeled the impact of prevention scenarios to 2035. Methods: We conducted an ecological analysis of 20,056 discharges diagnosed as laryngeal cancer (ICD-10 C32.x) between 2019 and 2023. Each episode was assigned a mean unit cost of 1100 USD, with age- and residence-specific adjustments, and re-priced using EU (3900 USD) and US (30,000 USD) tariffs. We derived annual costs and projected 2035 expenditure under three prevention scenarios. Results: Annual discharges fell from 5408 in 2019 to 3151\u20133212 in 2020\u20132021, then rose to 4409 in 2023, while inpatient spending ranged from 3.47 to 5.95 million USD, reaching 4.85 million USD in 2023 (22,200 USD\/100,000 population). Re-pricing 2023 activity at EU and US unit costs yielded counterfactual totals of 17.20 and 132.27 million USD. Older adults (\u226565 years) generated 47.6% of discharges and 49.1% of spending in 2023, and urban residence increased the odds of age \u226565 by 48% (OR 1.48, 95% CI 1.40\u20131.57). Without new prevention, costs are projected to reach 12.60 million USD by 2035; a 30% smoking reduction and a combined package including radon mitigation and dysphonia screening would lower 2035 costs to 10.33 and 9.07 million USD. Conclusions: Demographic aging and sustained case volume will markedly increase hospital costs, while prevention scenarios are associated with lower projected inpatient expenditure.<\/jats:p>","DOI":"10.3390\/healthcare14132007","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:43:11Z","timestamp":1783334591000},"page":"2007","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Future Inpatient Cost Burden of Laryngeal Cancer in Romania: Aging, Residence, and Prevention Scenarios in a Nationwide Ecological Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Andreea-Mihaela","family":"Ban\u021ba","sequence":"first","affiliation":[{"name":"Department of ENT, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Department of Otolaryngology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Stanga","sequence":"additional","affiliation":[{"name":"Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid-Denisa","family":"Barcan","sequence":"additional","affiliation":[{"name":"Department of ENT, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda-Ioana","family":"Morgovan","sequence":"additional","affiliation":[{"name":"Department of ENT, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Orasan","sequence":"additional","affiliation":[{"name":"Department of ENT, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"H\u00eertie","sequence":"additional","affiliation":[{"name":"Department of ENT, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-4608","authenticated-orcid":false,"given":"Nicolae-Constantin","family":"Balica","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina-Cristina","family":"Marin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3002-7656","authenticated-orcid":false,"given":"Mihaela-Cristina","family":"Negru","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-1263","authenticated-orcid":false,"given":"Delia Ioana","family":"Horhat","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4065-3650","authenticated-orcid":false,"given":"Marius","family":"Papurica","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care Research Center, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"ref_1","first-page":"e13689","article-title":"The global, regional, national burden of laryngeal cancer and its attributable risk factors (1990\u20132019) and predictions to 2035","volume":"31","author":"Lin","year":"2022","journal-title":"Eur. J. Cancer Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/JS9.0000000000000902","article-title":"Updated disease distributions, risk factors, and trends of laryngeal cancer: A global analysis of cancer registries","volume":"110","author":"Huang","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_3","first-page":"2248","article-title":"Laryngeal Cancer: Epidemiology, Etiology, and Prevention: A Narrative Review","volume":"52","author":"Igissin","year":"2023","journal-title":"Iran. J. Public Health"},{"key":"ref_4","unstructured":"National Cancer Institute (2025, December 02). SEER Cancer Stat Facts: Laryngeal Cancer, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/laryn.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40273-014-0169-3","article-title":"The economic burden of head and neck cancer: A systematic literature review","volume":"32","author":"Wissinger","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2016.08.018","article-title":"Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer","volume":"61","author":"Divi","year":"2016","journal-title":"Oral Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jamaoto.2018.3982","article-title":"Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors","volume":"145","author":"Massa","year":"2019","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_8","first-page":"e1528","article-title":"Out-of-pocket costs associated with head and neck cancer treatment","volume":"5","author":"Khan","year":"2022","journal-title":"Cancer Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11795549221147730","DOI":"10.1177\/11795549221147730","article-title":"Understanding Financial Toxicity in Patients with Head and Neck Cancer: A Systematic Review","volume":"17","author":"Patel","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e055213","DOI":"10.1136\/bmjopen-2021-055213","article-title":"Protocol for a systematic review of the financial burden experienced by people affected by head and neck cancer","volume":"12","author":"McCaffrey","year":"2022","journal-title":"BMJ Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe 2018","volume":"129","author":"Hofmarcher","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_12","unstructured":"Organisation for Economic Co-operation and Development, and European Commission (2023). EU Country Cancer Profile 2023: Romania, OECD Publishing."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Petre, I., Barna, F., Gurgus, D., Tomescu, L.C., Apostol, A., Petre, I., Furau, C., N\u0103chescu, M.L., and Bordianu, A. (2023). Analysis of the Healthcare System in Romania: A Brief Review. Healthcare, 11.","DOI":"10.3390\/healthcare11142069"},{"key":"ref_14","unstructured":"OECD, and European Observatory on Health Systems and Policies (2023). Romania: Country Health Profile 2023, OECD Publishing."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ban\u021ba, A.M., Balica, N.C., P\u00eervu, S., Marin, K.C., Guran, K., Barcan, I.D., Mo\u021b, C.I., H\u00eertie, B., Ban\u021ba, V., and Horhat, D.I. (2025). Evolution in Laryngeal Cancer Mortality at the National and Subnational Level in Romania with 2030 Forecast. Medicina, 61.","DOI":"10.3390\/medicina61101743"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jval.2024.01.007","article-title":"Cost of Illness of Head and Neck Cancer in Sweden","volume":"27","author":"Jarl","year":"2024","journal-title":"Value Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/CEOR.S198312","article-title":"Clinical and economic burden of head and neck cancer: A nationwide retrospective cohort study from France","volume":"11","author":"Schernberg","year":"2019","journal-title":"Clin. Outcomes Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2082192","DOI":"10.1080\/21645515.2022.2082192","article-title":"Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019","volume":"18","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_19","first-page":"203","article-title":"Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany","volume":"5","author":"Klussmann","year":"2013","journal-title":"Clin. Outcomes Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0194599810393117","article-title":"Cost-identification analysis of total laryngectomy: An itemized approach to hospital costs","volume":"144","author":"Dedhia","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chauhan, A.S., Prinja, S., Ghoshal, S., Verma, R., and Oinam, A.S. (2018). Cost of treatment for head and neck cancer in India. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191132"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Milani, V., Zara, A.L.S.A., da Silva, E.N., Cardoso, L.B., Curado, M.P., and Ribeiro-Rotta, R.F. (2021). Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246475"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100585","DOI":"10.1016\/j.clinsp.2025.100585","article-title":"Cost-consequence analysis of surgical and clinical treatment modalities of laryngeal cancer","volume":"80","author":"Lopez","year":"2025","journal-title":"Clinics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2340\/1651-226X.2025.43391","article-title":"Rural-urban and educational gradients in head and neck cancer incidence in Finland from 1977 to 2021","volume":"64","author":"Haapaniemi","year":"2025","journal-title":"Acta Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1002\/lary.31509","article-title":"Effect of Rurality in Head and Neck Cancer: A Scoping Review","volume":"134","author":"Tomescu","year":"2024","journal-title":"Laryngoscope"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1055-9965.EPI-22-0963","article-title":"Neighborhood Socioeconomic Status and Racial and Ethnic Survival Disparities in Oral Cavity and Laryngeal Cancer","volume":"32","author":"Liu","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e074723","DOI":"10.1136\/bmjopen-2023-074723","article-title":"Reduction of head and neck cancer risk following smoking cessation: A systematic review and meta-analysis","volume":"14","author":"Khalifeh","year":"2024","journal-title":"BMJ Open"},{"key":"ref_28","first-page":"45","article-title":"Smoking cessation interventions in patients diagnosed with head and neck cancers: A systematic review of randomized controlled trials","volume":"17","author":"Gaikwad","year":"2023","journal-title":"Int. J. Health Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2216362","DOI":"10.1001\/jamanetworkopen.2022.16362","article-title":"Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer","volume":"5","author":"Levy","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41416-024-02819-z","article-title":"Cost-effectiveness of point of care smoking cessation interventions in oncology clinics","volume":"131","author":"Mullen","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kostadinov, K., Popova-Sotirova, I., Marinova, Y., Musurlieva, N., Iskrov, G., and Stefanov, R. (2024). Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures. Cancers, 16.","DOI":"10.3390\/cancers16081489"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kostadinov, K., Iskrov, G., Musurlieva, N., and Stefanov, R. (2025). An Evaluation of Rare Cancer Policies in Europe: A Survey Among Healthcare Providers. Cancers, 17.","DOI":"10.3390\/cancers17020164"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/13\/2007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:32:42Z","timestamp":1783341162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/13\/2007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":32,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["healthcare14132007"],"URL":"https:\/\/doi.org\/10.3390\/healthcare14132007","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}